Rationale and design of the Duke Electrophysiology Genetic and Genomic Studies (EPGEN) biorepository.

[1]  H. Krumholz,et al.  Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. , 2009, JAMA.

[2]  D. Glower,et al.  Metabolomic Profiling Reveals Distinct Patterns of Myocardial Substrate Use in Humans With Coronary Artery Disease or Left Ventricular Dysfunction During Surgical Ischemia/Reperfusion , 2009, Circulation.

[3]  Christian Gieger,et al.  Common variants at ten loci modulate the QT interval duration in the QTSCD Study , 2009, Nature Genetics.

[4]  Thomas Lumley,et al.  Common variants at ten loci influence QT interval duration in the QTGEN Study , 2009, Nature Genetics.

[5]  D. Levy,et al.  Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study , 2009, The Lancet.

[6]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[7]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[8]  Geoffrey S Ginsburg,et al.  Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery Stenosis , 2008, Circulation. Cardiovascular genetics.

[9]  B. Lindsay,et al.  Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. , 2008, Heart rhythm.

[10]  Jeroen J. Bax,et al.  Results of the Predictors of Response to CRT (PROSPECT) Trial , 2008, Circulation.

[11]  P. Denes,et al.  Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT). , 2007, The American journal of cardiology.

[12]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .

[13]  Stephen S. Cha,et al.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.

[14]  Jagmeet P. Singh,et al.  Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). , 2005, Journal of the American College of Cardiology.

[15]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[16]  A. Moss,et al.  Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). , 2004, Journal of the American College of Cardiology.

[17]  A. Chakravarti,et al.  Genomics in sudden cardiac death. , 2004, Circulation research.

[18]  Heikki V Huikuri,et al.  Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. , 2003, Circulation.

[19]  B. Radovancević,et al.  Prolonged QTc Interval and High B-Type Natriuretic Peptide Levels Together Predict Mortality in Patients With Advanced Heart Failure , 2003, Circulation.

[20]  Eden Martin,et al.  Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage. , 2003, Human molecular genetics.

[21]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[22]  M. Brodsky,et al.  Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study , 2000, Circulation.

[23]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[24]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[25]  H. Elming,et al.  Classification of Sudden and Arrhythmic Death , 1997, Pacing and clinical electrophysiology : PACE.

[26]  R. Myerburg,et al.  Sudden Cardiac Death: Epidemiology, Transient Risk, and Intervention Assessment , 1993, Annals of Internal Medicine.

[27]  A. Tonkin,et al.  Atrial Fibrillation: Epidemiology and the Risk and Prevention of Stroke , 1992, Pacing and clinical electrophysiology : PACE.

[28]  J. Vandenbroucke,et al.  QT Interval Prolongation Predicts Cardiovascular Mortality in an Apparently Healthy Population , 1991, Circulation.

[29]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[30]  L E Hinkle,et al.  Clinical Classification of Cardiac Deaths , 1982, Circulation.